MedPath
HSA Approval

CLOPIGREL TABLET 75MG

SIN14924P

CLOPIGREL TABLET 75MG

CLOPIGREL TABLET 75MG

January 21, 2016

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AC04

clopidogrel

Manufacturer Information

ZYFAS MEDICAL CO

USV Limited

Active Ingredients

CLOPIDOGREL BISULFATE 97.875 mg EQV CLOPIDOGREL

75 mg

Clopidogrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.